Heart Health Supplements Market

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USPs / Features

    4.3. Strategic Promotional Strategies

5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018-2023 and Forecast, 2023-2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018-2023

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Global Urbanization Growth Outlook

        6.1.3. Global Food Security Index Outlook

        6.1.4. Global Rank – Ease of Doing Business

        6.1.5. Global Rank – Trading Across Borders

    6.2. Global Nutraceutical Market Overview

    6.3. Global Dietary Supplements Market Overview

        6.3.1. Global Dietary Supplements Market Analysis and Forecast by Country, 2023-2033

    6.4. Opportunities in Nutritional Supplements Industry

    6.5. Opportunities for New Market Players in Asia-Pacific Dietary Supplement Market

    6.6. Consumer Spending Pattern: Prevention over Treatment, Global

    6.7. Distribution Transformation for Dietary Supplements

    6.8. Consumer Health Industry Value Chain

    6.9. Value Chain

        6.9.1. Profit Margin Analysis at each point of sales

        6.9.2. List and Role of Key Participants

            6.9.2.1. Producers/Processors

            6.9.2.2. Distributors/Suppliers/Wholesalers

            6.9.2.3. End Users

    6.10. Market Dynamics

        6.10.1. Drivers

        6.10.2. Restraints

        6.10.3. Opportunity Analysis

    6.11. Key Regulations - Dietary Supplements

    6.12. Forecast Factors - Relevance & Impact

7. Global Market Analysis 2018-2023 and Forecast 2023-2033, By Form

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) By Form 2018-2023

    7.3. Current and Future Market Size (US$ Mn) and Forecast By Form, 2023-2033

        7.3.1. Powder

        7.3.2. Liquid

        7.3.3. Soft Gels & Pills

    7.4. Market Attractiveness Analysis By Form

8. Global Market Analysis 2018-2023 and Forecast 2023-2033, By Ingredient

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) By Ingredient, 2018-2023

    8.3. Current and Future Market Size (US$ Mn) and Forecast By Ingredient, 2023-2033

        8.3.1. Vitamins & Minerals

        8.3.2. Amino Acids

        8.3.3. Botanical Supplements

        8.3.4. Others

    8.4. Market Attractiveness Analysis By Sales Channel

9. Global Market Analysis 2018-2023 and Forecast 2023-2033, By Sales Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) By Sales Channel, 2018-2023

    9.3. Current and Future Market Size (US$ Mn) and Forecast By Sales Channel, 2023-2033

        9.3.1. Hypermarkets/Supermarkets

        9.3.2. Drug & Specialty Stores

        9.3.3. Online Retail

        9.3.4. Other Retail Formats

    9.4. Market Attractiveness Analysis By Sales Channel

10. Global Market Analysis 2018-2023 and Forecast 2023-2033, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) By Region, 2018-2023

    10.3. Current Market Size (US$ Mn) and Forecast By Region, 2023-2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. East Asia

        10.3.5. South Asia and Pacific

        10.3.6. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2018-2023 and Forecast 2023-2033

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2018-2023

    11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023-2033

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Form

        11.3.3. By Ingredient

        11.3.4. By Sales Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Form

        11.4.3. By Ingredient

        11.4.4. By Sales Channel

12. Latin America Market Analysis 2018-2023 and Forecast 2023-2033

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2018-2023

    12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023-2033

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Rest of Latin America

        12.3.2. By Form

        12.3.3. By Ingredient

        12.3.4. By Sales Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Form

        12.4.3. By Ingredient

        12.4.4. By Sales Channel

13. Europe Market Analysis 2018-2023 and Forecast 2023-2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2018-2023

    13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023-2033

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. Italy

            13.3.1.3. France

            13.3.1.4. U.K.

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Nordic

            13.3.1.8. Russia

            13.3.1.9. Poland

            13.3.1.10. Rest of Europe

        13.3.2. By Nature

        13.3.3. By Form

        13.3.4. By Ingredient

        13.3.5. By Sales Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Form

        13.4.3. By Ingredient

        13.4.4. By Sales Channel

14. South Asia and Pacific Market Analysis 2018-2023 and Forecast 2023-2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2018-2023

    14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023-2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. ASEAN

            14.3.1.3. Oceania (New Zealand and Australia)

            14.3.1.4. Rest of South Asia and Pacific

        14.3.2. By Form

        14.3.3. By Ingredient

        14.3.4. By Sales Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Form

        14.4.3. By Ingredient

        14.4.4. By Sales Channel

15. East Asia Market Analysis 2018-2023 and Forecast 2023-2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2018-2023

    15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023-2033

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Form

        15.3.3. By Ingredient

        15.3.4. By Sales Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Form

        15.4.3. By Ingredient

        15.4.4. By Sales Channel

16. Middle East and Africa Market Analysis 2018-2023 and Forecast 2023-2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2018-2023

    16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2023-2033

        16.3.1. By Country

            16.3.1.1. GCC Countries

            16.3.1.2. South Africa

            16.3.1.3. Rest of Middle East and Africa

        16.3.2. By Form

        16.3.3. By Ingredient

        16.3.4. By Sales Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Form

        16.4.3. By Ingredient

        16.4.4. By Sales Channel

17. Market Structure Analysis

    17.1. Market Analysis by Tier of Companies

    17.2. Market Concentration

    17.3. Market Presence Analysis

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Competition Deep Dive

        18.3.1. Bayer AG

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio/Key Brands

            18.3.1.3. Sales Footprint

            18.3.1.4. Key Developments/Key Takeaways

            18.3.1.5. Strategy Overview

            18.3.1.6. Financial Overview

        18.3.2. USANA Health Sciences, Inc.

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio/Key Brands

            18.3.2.3. Sales Footprint

            18.3.2.4. Key Developments/Key Takeaways

            18.3.2.5. Strategy Overview

            18.3.2.6. Financial Overview

        18.3.3. Sanofi

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio/Key Brands

            18.3.3.3. Sales Footprint

            18.3.3.4. Key Developments/Key Takeaways

            18.3.3.5. Strategy Overview

            18.3.3.6. Financial Overview

        18.3.4. Koninklijke DSM N.V.

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio/Key Brands

            18.3.4.3. Sales Footprint

            18.3.4.4. Key Developments/Key Takeaways

            18.3.4.5. Strategy Overview

            18.3.4.6. Financial Overview

        18.3.5. Pfizer Inc.

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio/Key Brands

            18.3.5.3. Sales Footprint

            18.3.5.4. Key Developments/Key Takeaways

            18.3.5.5. Strategy Overview

            18.3.5.6. Financial Overview

        18.3.6. Abbott Laboratories

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio/Key Brands

            18.3.6.3. Sales Footprint

            18.3.6.4. Key Developments/Key Takeaways

            18.3.6.5. Strategy Overview

            18.3.6.6. Financial Overview

        18.3.7. Herbalife Nutrition Ltd.

            18.3.7.1. Overview

            18.3.7.2. Product Portfolio/Key Brands

            18.3.7.3. Sales Footprint

            18.3.7.4. Key Developments/Key Takeaways

            18.3.7.5. Strategy Overview

            18.3.7.6. Financial Overview

        18.3.8. GNC Holdings Inc

            18.3.8.1. Overview

            18.3.8.2. Product Portfolio/Key Brands

            18.3.8.3. Sales Footprint

            18.3.8.4. Key Developments/Key Takeaways

            18.3.8.5. Strategy Overview

            18.3.8.6. Financial Overview

        18.3.9. Chr. Hansen Holding A/S

            18.3.9.1. Overview

            18.3.9.2. Product Portfolio/Key Brands

            18.3.9.3. Sales Footprint

            18.3.9.4. Key Developments/Key Takeaways

            18.3.9.5. Strategy Overview

            18.3.9.6. Financial Overview

        18.3.10. BASF SE

            18.3.10.1. Overview

            18.3.10.2. Product Portfolio/Key Brands

            18.3.10.3. Sales Footprint

            18.3.10.4. Key Developments/Key Takeaways

            18.3.10.5. Strategy Overview

            18.3.10.6. Financial Overview

        18.3.11. Amway

            18.3.11.1. Overview

            18.3.11.2. Product Portfolio/Key Brands

            18.3.11.3. Sales Footprint

            18.3.11.4. Key Developments/Key Takeaways

            18.3.11.5. Strategy Overview

            18.3.11.6. Financial Overview

        18.3.12. NOW Health Group, INC.

            18.3.12.1. Overview

            18.3.12.2. Product Portfolio/Key Brands

            18.3.12.3. Sales Footprint

            18.3.12.4. Key Developments/Key Takeaways

            18.3.12.5. Strategy Overview

            18.3.12.6. Financial Overview

        18.3.13. Nutramax Laboratories, INC.

            18.3.13.1. Overview

            18.3.13.2. Product Portfolio/Key Brands

            18.3.13.3. Sales Footprint

            18.3.13.4. Key Developments/Key Takeaways

            18.3.13.5. Strategy Overview

            18.3.13.6. Financial Overview

        18.3.14. The Nature's Bounty Co.

            18.3.14.1. Overview

            18.3.14.2. Product Portfolio/Key Brands

            18.3.14.3. Sales Footprint

            18.3.14.4. Key Developments/Key Takeaways

            18.3.14.5. Strategy Overview

            18.3.14.6. Financial Overview

        18.3.15. Nature's Way Products, LLC.

            18.3.15.1. Overview

            18.3.15.2. Product Portfolio/Key Brands

            18.3.15.3. Sales Footprint

            18.3.15.4. Key Developments/Key Takeaways

            18.3.15.5. Strategy Overview

            18.3.15.6. Financial Overview

        18.3.16. Viva Naturals

            18.3.16.1. Overview

            18.3.16.2. Product Portfolio/Key Brands

            18.3.16.3. Sales Footprint

            18.3.16.4. Key Developments/Key Takeaways

            18.3.16.5. Strategy Overview

            18.3.16.6. Financial Overview

        18.3.17. NutraMarks, Inc.

            18.3.17.1. Overview

            18.3.17.2. Product Portfolio/Key Brands

            18.3.17.3. Sales Footprint

            18.3.17.4. Key Developments/Key Takeaways

            18.3.17.5. Strategy Overview

            18.3.17.6. Financial Overview

        18.3.18. Vitabiotics Ltd

            18.3.18.1. Overview

            18.3.18.2. Product Portfolio/Key Brands

            18.3.18.3. Sales Footprint

            18.3.18.4. Key Developments/Key Takeaways

            18.3.18.5. Strategy Overview

            18.3.18.6. Financial Overview

        18.3.19. Vitamin Shopee, Inc.

            18.3.19.1. Overview

            18.3.19.2. Product Portfolio/Key Brands

            18.3.19.3. Sales Footprint

            18.3.19.4. Key Developments/Key Takeaways

            18.3.19.5. Strategy Overview

            18.3.19.6. Financial Overview

        18.3.20. Pure Encapsulations, LLC

            18.3.20.1. Overview

            18.3.20.2. Product Portfolio/Key Brands

            18.3.20.3. Sales Footprint

            18.3.20.4. Key Developments/Key Takeaways

            18.3.20.5. Strategy Overview

            18.3.20.6. Financial Overview

19. Assumptions and Acronyms Used

20. Research Methodology